Could IFN-γ predict the development of residual pleural thickening in tuberculous pleurisy?

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 69, Issue 1, 2008, Pages 18-23

  Gerogianni, I ^a   Papala, M ^a   Tsopa, P ^a   Zigoulis, P ^a   Dimoulis, A ^a   Kostikas, K ^a   Kiropoulos, T ^a   Gourgoulianis, K I ^a  

^a University of Thessaly School of Medicine   (Greece)

Author keywords

Adenosine deaminase; Interferon ; Pleural thickening; Tuberculosis pleurisy

Indexed keywords

ADENOSINE DEAMINASE; BIOLOGICAL MARKER; ETHAMBUTOL; GAMMA INTERFERON; GLUCOSE; ISONIAZID; LACTATE DEHYDROGENASE; PROTEIN; PYRAZINAMIDE; RIFAMPICIN; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE MARKER; DYSPNEA; FATIGUE; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MYCOBACTERIUM TUBERCULOSIS; NIGHT SWEAT; PH MEASUREMENT; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA FLUID; PLEURA THICKENING; PREDICTION; RETROSPECTIVE STUDY; SMOKING; SPUTUM ANALYSIS; THORACOCENTESIS; THORAX PAIN; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOUS PLEURISY; WEIGHT REDUCTION;

EID: 42549107766     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2008.407     Document Type: Article

References (27)

1. Kumar D, Watson JM, Charlett A, Nicholas S, Darbyshire JH. Tuberculosis in England and Wales in 1993: results of a national survey. Thorax 1997; 52: 1060-1067.
2. Akotgu S, Yorgancioglu A, Cirak K, Kose T, Dereli SM. Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5480 cases. Eur Respir J 1996; 9: 2031-2035.
3. Chan CHS, Arnold M, Chan CY, et al. Clinical and pathological features of tuberculous pleural effusion and its long-term consequences. Respiration 1991; 58: 171-75.
4. Valdes L, San Jose E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 1993; 103: 458-65.
5. Grove CS, Lee YC. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 2002; 8: 294-301.
6. Hamed EA, El-Noweihi AM, Mohamed AZ, Mahmound A. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions. Respirology 2004; 9: 81-86.
7. Giusti G. Adenosine deaminase. In: Bergmeyer HU, ed. Methods of enzymate analysis. New York, NY: Academic Press, 1974; 1092-1099.
8. Light RW. Pleural disease. 3rd ed. Baltimore: Williams & Wilkins, 1990.
9. Lee CH, Wang WJ, Lan RS, et al. Corticosteroids in the treatment of tuberculous pleurisy: a double-blind, placebo-controlled, randomised study. Chest 1988; 94: 1256-59.
10. Barbas CS, Cukier A, Varvalho CR, Barbas Filho TV, Light RW. The relationship between pleural fluid findings and the development of pleural thichening in patients with pleural tuberculosis. Chest 1991; 100: 1264-67.
11. Soler JJ, Gil Suay V, Cordero P, et al. Corticoids en la tuberculosis pleural i Reducen el engrosamiento pleural residual [abstract]? Arch Bronconeumol 1994; 30 (suppl 1): 43.
12. Wyser C, Walzi G, Smedema J, et al. Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest 1996; 110: 333-8.
13. Pablo A, Villena V, Echave-Sustaena J, Enchuetra Argel Lopez. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 1997; 112: 1293-1297.
14. Uskul B, Turker H, Ulman C, Ertgrul M. The relation of pleural thickening in tuberculosis pleurisy with the activity of adenosine deaminase. Monaldi Arch Chest Dis 2005; 63: 101-107.
15. Gourgoulianis K.I. Diagnostic value of adenosine deaminase activity in tuberculous effusions. Eur Res J 1990; 3: 1098.
16. Ocana I, Martinez-Vazquez JM, Segura RM, Fernandez-De-Senllaj, Capdevila JA. Adenosine deaminase in pleural fluids: test for diagnosis of tuberculous pleural effusion. Chest 1983; 84: 51-53.
17. Burgess LJ, Maritz FJ, Le Roux I, Taljaard JJ. Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax 1995; 50: 672-674.
18. Perez- Rodriguez E, Castro DJ. The use of ADA and ADA isoenzymes in the diagnosis of tuberculous pleurisy. Curr Opin 2000; 6: 259-266.
19. Cheng D, Rodriguez RM, Perkett EA, Rogers J, Bienvenu G, Light RW. Vascular endothelial growth factor in pleural fluid. Chest 1999; 115: 760-765.
20. Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI. Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir Res 2006; 7: 128.
21. Alatas F, Alatas Oz, Metintas M, et al. Vascular endothelial growth factor levels in active tuberculosis. Chest 2004; 125: 2156-2159.
22. Kraft A, Weinkel K, Ochs A, Marth C, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and non-malignant disease. Cancer 1999; 85: 178-187.
23. Sack U, Hoffmann M, Zhao XJ, et al. Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 2005; 25: 600-604.
24. Kiropoulos TS, Kostikas K, Gourgoulianis KI. Vascular endothelial growth factor levels in pleural and serum of patients with tubeculus pleural effusions. Chest 2005; 128: 468-469.
25. Ribera E, Ocana I, Martinez-Vazquez JM, Rossell M, Espanol T, et al. High level of interferon gamma in tuberculous pleural effusions. [i Chest 1988; 93: 308-311.
26. Vilena V, Lopez-Encuentra A, Echave-Sustaeta J, et al. Interferon-gamma in 338 immunocompromized and immunocompetent patients for diagnosing pleural tuberculosis. Eur Respir J 1996; 9: 2635-2639.
27. Kim YK, Lee SY, Kwon SS, Kim KH, Moon HS, et al. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion. Lung 2001; 179: 175-184.